SCHEMBL29935587

SCHEMBL29935587

O=Cc1n[nH]c2ncccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.50
▸ AURKA O14965 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ AXL P30530 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ERN1 O75460 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MET P08581 2/20 0.37
▸ GPR84 Q9NQS5 1/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ TRIM24 O15164 1/20 0.36
▸ TRIM33 Q9UPN9 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.35
▸ MAP2K1 Q02750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1639313 1.00 KMT2A (0.50) KMT2AAURKAPARP1AXLKDM4E
SCHEMBL12336934 0.79 KMT2A (0.37) KMT2AAURKAPARP1AXLKDM4E
SCHEMBL10126734 0.77 KMT2A (0.40) KMT2AAURKAPARP1KDM4EMEN1
SCHEMBL4668018 0.76 CAMKK2 (0.38) KMT2AAURKAPARP1KDM4EFEN1
SCHEMBL4667699 0.76 CAMKK2 (0.38) KMT2AAURKAPARP1KDM4EFEN1
SCHEMBL4776889 0.74 CCNC (0.42) KMT2AAURKAAXLMEN1MET
SCHEMBL4776882 0.74 CCNC (0.42) KMT2AAURKAAXLMEN1MET
SCHEMBL30631993 0.72 PDPK1 (0.48) KMT2AAURKAPARP1AXLKDM4E
SCHEMBL1495296 0.72 PDPK1 (0.48) KMT2AAURKAPARP1AXLKDM4E
SCHEMBL174642 0.72 PDPK1 (0.48) KMT2AAURKAPARP1AXLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 — — CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 — — US disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 — — CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 — — US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 — — US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP KMT2A 1069/4885AURKA 3364/4885PARP1 2910/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH KMT2A 3729/4885AURKA 4623/4885PARP1 3778/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP KMT2A 1069/4885AURKA 3364/4885PARP1 2910/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP KMT2A 1069/4885AURKA 3364/4885PARP1 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback